+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Rhabdomyolysis after co-administration of a statin and fusidic acid: an analysis of the literature and of the WHO database of adverse drug reactions



Rhabdomyolysis after co-administration of a statin and fusidic acid: an analysis of the literature and of the WHO database of adverse drug reactions



British Journal of Clinical Pharmacology 84(5): 1057-1063



Following a severe case of rhabdomyolysis in our University Hospital after a co-administration of atorvastatin and fusidic acid, we describe this interaction as this combination is not clearly contraindicated in some countries, particularly for long-term treatment by fusidic acid. All cases of rhabdomyolysis during a co-administration of a statin and fusidic acid were identified in the literature and in the World and Health Organization database, VigiBase® . In the literature, 29 cases of rhabdomyolysis were identified; mean age was 66 years, median duration of co-administration before rhabdomyolysis occurrence was 21 days, 28% of cases were fatal. In the VigiBase® , 182 cases were retrieved; mean age was 68 years, median duration of co-administration before rhabdomyolysis was 31 days and 24% of cases were fatal. Owing to the high fatality associated with this co-administration and the long duration of treatment before rhabdomyolysis occurrence, fusidic acid should be used if there is no appropriate alternative, as long as statin therapy is interrupted for the duration of fusidic acid therapy, and perhaps a week longer. Rarely will interruption of this sort have adverse consequences for the patient.

(PDF emailed within 0-6 h: $19.90)

Accession: 065483714

Download citation: RISBibTeXText

PMID: 29337401

DOI: 10.1111/bcp.13515


Related references

Healthcare professionals and pharmacovigilance of pediatric adverse drug reactions: a 5-year analysis of Adverse Events Reporting System database of the Food and Drug Administration. Minerva Pediatrica 2017, 2017

Adverse Drug Reactions, Medication Adherence and Physicians' Prescribing Behavior: Which Relationship? a Database Analysis on Statin use. Value in Health 18(7): A374, 2015

Levetiracetam-induced rhabdomyolysis: Analysis of reports from the Food and Drug Administration's Adverse Event Reporting System database. Muscle and Nerve 56(6): E176-E178, 2017

Muscle Damage Due to Fusidic Acid-Statin Interaction: Review of 75 Cases From the French Pharmacovigilance Database and Literature Reports. American Journal of Therapeutics 2017, 2017

Adverse reactions to intravenous administration of fusidic acid. Scandinavian Journal of Infectious Diseases 13(1): 65-67, 1981

Rhabdomyolysis after co-prescription of statin and fusidic acid. Bmj 345: E6562, 2012

Fusidic acid adverse drug reactions. International Journal of Antimicrobial Agents 12(SUPPL 2): S3-S9, 1999

Statin-associated psychiatric adverse events: A case/non case evaluation of an Italian database of spontaneous reporting of adverse drug reactions. 2007

Consumer reporting of adverse drug reactions: a retrospective analysis of the Danish adverse drug reaction database from 2004 to 2006. Drug Safety 32(11): 1067-1074, 2009

Association between infection and severe drug adverse reactions: an analysis using data from the Japanese Adverse Drug Event Report database. European Journal of Clinical Pharmacology 73(12): 1643-1653, 2017

Methodology for Estimating the Risk of Adverse Drug Reactions in Pregnant Women: Analysis of the Japanese Adverse Drug Event Report Database. Yakugaku Zasshi 136(3): 499-505, 2017

Severe statin-induced rhabdomyolysis mimicking Guillain-Barré syndrome in four patients with diabetes mellitus treated with fusidic acid. Diabetic Medicine 27(6): 696-700, 2011

Analysis of data on capecitabine-related adverse drug reactions from the Korean adverse event reporting system database. European Journal of Oncology Nursing 34: 55-60, 2018

Analysis of data on capecitabine-related adverse drug reactions from the Korean adverse event reporting system database. European Journal of Oncology Nursing 34: 55-60, 2018

Quantitative Evaluation of Initial Symptoms as Predictors to Detect Adverse Drug Reactions Using Bayes Theory: Expansion and Evaluation of Drug-Adverse Drug ReactionInitial Symptom Combinations Using Adverse Event Reporting System Database. Biological & Pharmaceutical Bulletin 36(12): 1891-1901, 2013